Cargando…

Covid-19–Associated Myopathy Caused by Type I Interferonopathy

Detalles Bibliográficos
Autores principales:	Manzano, Giovanna S., Woods, Jared K., Amato, Anthony A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722689/ https://www.ncbi.nlm.nih.gov/pubmed/33216474 http://dx.doi.org/10.1056/NEJMc2031085

Ejemplares similares

Type I Interferonopathies in Childhood
por: Haşlak, Fatih, et al.
Publicado: (2023)

Type I interferonopathies in pediatric rheumatology
por: Volpi, Stefano, et al.
Publicado: (2016)

Type I Interferonopathies in Children: An Overview
por: d'Angelo, Debora M., et al.
Publicado: (2021)

The type I interferonopathies: 10 years on
por: Crow, Yanick J., et al.
Publicado: (2021)

Myopathy associated with COVID-19
por: Hsueh, Sung-Ju, et al.
Publicado: (2021)

Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview
por: Rodero, Mathieu P., et al.
Publicado: (2016)

Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy
por: Meesilpavikkai, Kornvalee, et al.
Publicado: (2019)

Lung involvement in monogenic interferonopathies
por: Cazzato, Salvatore, et al.
Publicado: (2020)

Myasthenia Gravis: An Acquired Interferonopathy?
por: Payet, Cloé A., et al.
Publicado: (2022)

Clinical spectrum and currently available treatment of type I interferonopathy Aicardi–Goutières syndrome
por: Dell’Isola, Giovanni Battista, et al.
Publicado: (2023)

Human RELA dominant-negative mutations underlie type I interferonopathy with autoinflammation and autoimmunity
por: Moriya, Kunihiko, et al.
Publicado: (2023)

Monogenic interferonopathy presenting as CMV infection in infancy
por: Schütz, C, et al.
Publicado: (2015)

ZBP1 contributes to interferonopathies caused by impaired ADAR1 function
por: Fang, Xiuwu, et al.
Publicado: (2022)

Fine-tuning of type I IFN-signaling in microglia — implications for homeostasis, CNS autoimmunity and interferonopathies
por: Goldmann, Tobias, et al.
Publicado: (2016)

Type I Interferonopathy due to a Homozygous Loss-of-Inhibitory Function Mutation in STAT2
por: Zhu, Gaofeng, et al.
Publicado: (2023)

Identification of type I interferonopathies using blood interferon signature: the experience of a pediatric rheumatology center
por: Volpi, S, et al.
Publicado: (2015)

Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)
por: Kanazawa, Nobuo, et al.
Publicado: (2023)

Human Disease Phenotypes Associated with Loss and Gain of Function Mutations in STAT2: Viral Susceptibility and Type I Interferonopathy
por: Duncan, Christopher James Arthur, et al.
Publicado: (2021)

Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy
por: Gruber, Conor, et al.
Publicado: (2020)

Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinib
por: Zhang, Shiyu, et al.
Publicado: (2021)

Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China
por: Li, Wendao, et al.
Publicado: (2022)

A novel MAP3K20 mutation causing centronuclear myopathy-6 with fiber-type disproportion in a Pakistani family
por: Ahmad, Ilyas, et al.
Publicado: (2022)

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
por: Sanchez, Gina A. Montealegre, et al.
Publicado: (2018)

Does prolonged propofol sedation of mechanically ventilated COVID-19 patients contribute to critical illness myopathy?
por: Lönnqvist, Per-Arne, et al.
Publicado: (2020)

A recurrent homozygous ACTN2 variant associated with core myopathy
por: Inoue, Michio, et al.
Publicado: (2021)

Letter to the Editor: Propacetamol-Induced Rhabdomyolysis or COVID-Vaccine-Related Inflammatory Myopathy?
por: Finsterer, Josef
Publicado: (2022)

Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition
por: Galbraith, Matthew D., et al.
Publicado: (2023)

Type 1 Diabetes and Type 1 Interferonopathies: Localization of a Type 1 Common Thread of Virus Infection in the Pancreas
por: Jean-Baptiste, Virginie S.E., et al.
Publicado: (2017)

Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome
por: Meuwissen, Marije E.C., et al.
Publicado: (2016)

Obesity and Mortality in COVID-19: Cause or Association?
por: Anand, Abhinav, et al.
Publicado: (2023)

Mosaic tetrasomy 9p: a mendelian interferonopathy associated with pediatric-onset overlap myositis
por: Frémond, M-L, et al.
Publicado: (2015)

Capture myopathy in hooved mammals and human Takotsubo syndrome
por: Madias, John E.
Publicado: (2015)

Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies
por: Kim, Hanna, et al.
Publicado: (2020)

Interferonopathies masquerading as non-Mendelian autoimmune diseases: pattern recognition for early diagnosis
por: Gagne, Samuel, et al.
Publicado: (2023)

A case of type I Kounis syndrome caused by double allergens
por: Zhang, Yi-Xuan, et al.
Publicado: (2020)

Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype
por: Clarke, S. L. N., et al.
Publicado: (2020)

Two novel ETFDH mutations in a patient with lipid storage myopathy
por: Xu, Hong-Liang, et al.
Publicado: (2019)

HDAC stimulates gene expression through BRD4 availability in response to IFN and in interferonopathies
por: Marié, Isabelle J., et al.
Publicado: (2018)

Clinical, Pathological, and Genetic Features of Two Chinese Cases with Filamin C Myopathy
por: Zhang, Yu-Tong, et al.
Publicado: (2018)

Plasmacytoid dendritic cells and type I interferons in flares of systemic lupus erythematosus triggered by COVID-19
por: Nasser, Nourhane, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_57nap5065jsrs05hg74kjcafpq